Clinical trials: Moderate or Severe Opioid Use Disorder

Moderate or Severe Opioid Use Disorder

A Multiple Dose Opioid Challenge Study

• Completed
• Age: 18 to 55 years
• Phase 2
• Results posted

Multi-site, randomized, double-blind, repeat-dose Phase 2 study to evaluate the degree and duration of action of multiple doses of CAM2038 in blocking the effects of hydromorphone in patients with moderate or severe opioid use…

Trial name

NCT02611752

Testing

CAM2038

Where

3 sites in United States

Volunteers

47 people

Sponsor

Braeburn Pharmaceuticals